Gastrointestinal surgery for severe obesity. Obes Surg 1991;1(3):257-265.
‘Bariatric surgery: a systematic review and meta-analysis’. J Am Med Assoc 2004;292(14):1724-1737.
Effects of gastric bypass surgery in patients with type-2 diabetes and only mild obesity. Diabetes Care 2012 Jul;35(7):1420-1428.
Laparoscopic Roux-en-Y gastric bypass for non-obese type II diabetes mellitus in Asian patients. Surg Obesity Related Dis 2014 Sep-Oct;10(5):834-840.
Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m2: a tailored approach. Surg Obes Related Dis 2006;2(3):401-404.
Changes of blood glucose and gastrointestinal hormones 4 months after Roux-en-Y gastric bypass surgery in Chinese obese type-2 diabetes patients with lower body mass index. J Diabetes Investig 2013 Mar 18;4(2):214-221.
Bariatric surgery in moderately obese patients: a prospective study. Gastroenterol Res Pract 2013 2013;276183.
Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012 Apr 26;366(17):1577-1585.
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update. American Association of Clinical Endocrinologists. The Obesity Society, and American Society for Metabolic and Bariatric Surgery. Endocr Pract 2013 Mar 26.
Weight and T2DM after bariatric surgery: systematic review and meta-analysis. Am J Med 2009 Mar;122(3):248-256.
Long-term mortality after gastric bypass surgery. N Engl J Med 2007 Aug 23;357(8):753-761.
Improvement in insulin sensitivity and B-cell function following ileal interposition with sleeve gastrectomy in type-2 diabetic patients: potential mechanisms. J Gastrointest Surg 2011 Aug;15(8):1344-1353.
Laparoscopic treatment of type-2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 2008;22:706-716.
Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes. World J Surg 2009 Oct;33(10):2014-2021.
Improvement of type-2 diabetes mellitus in obese and nonobese patients after the duodenal switch operation. J Obesity 2011 Mar 3; 2011:860169.
The preliminary clinical experience with laparoscopic duodenojejunal bypass for treatment of type-2 diabetes mellitus in nonmorbidly obese patients: the 1-year result in a single institute. Surg Endosc DOI: 10.1007/s00464-012-2341-1. 08 June 2012.
Surgical treatment of type-2 diabetes in patients with BMI below 35: mid-term outcomes of the laparoscopic ileal interposition associated with a sleeve gastrectomy in 202 consecutive cases. J Gastrointest Surg 2012 May;16(5):967-976.
United Kingdom prospective diabetes study (UKPDS) group. The UKPDS risk engine: a model for the risk of coronary heart disease in type-2 diabetes (UKPDS 56). Clin Sci (Lond) 2001;101:671-679.
Interactions between gut peptides and the central melanocortin system in the regulation of energy homeostasis. Peptides 2006 Feb;27(2):340-349.Epub 2005 Nov 22.
Glucagon-like peptides: regulators of cell proliferation, differentiation and apoptosis. Mol Endocrinol 2003 Feb;17(2):161-171.
Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type-2 diabetes. J Clin Endocrinol Metab 2008 Jul;93(7):2479-2485.
Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008 Mar;247(3):401-407.